Literature DB >> 16827896

Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells.

Marko Janke1, Esther J Witsch, Hans W Mages, Andreas Hutloff, Richard A Kroczek.   

Abstract

CD4+ CD45RO+ T cells could mature freshly isolated human plasmacytoid dendritic cells (PDC) in a superantigen-driven culture in a similar way to recombinant interleukin-3 (IL-3). Mature PDC expressed significantly higher levels of inducible costimulator ligand (ICOS-L), but similar levels of CD80 and CD86, when compared to mature monocyte-derived DC (moDC). We therefore directly compared the capacities of mature PDC and moDC to activate T cells. A similar T helper type 1 (Th1)/Th2 pattern of cytokines was generated in both systems, but significantly higher levels of IL-3, IL-4 and IL-10 were induced by PDC. In T cells interacting with PDC, the ICOS/ICOS-L costimulatory pathway played a pre-eminent role in the generation of IL-3 and IL-10, CD28 was central to the induction of IL-2, and both pathways were equally important for the generation of other cytokines. In cocultures with moDC, the CD28 pathway was dominant over ICOS under all circumstances, except for the ICOS-mediated release of IL-10. In general, our data demonstrate an eminent role of ICOS in the interaction of T cells with PDC, and thus modify the current paradigm of CD28 dominance for the costimulation of T cells interacting with professional antigen-presenting cells. In particular, our data highlight the role of ICOS in the generation of IL-3, a factor central to the biology of human PDC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827896      PMCID: PMC1782304          DOI: 10.1111/j.1365-2567.2006.02379.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.

Authors:  S Wang; G Zhu; A I Chapoval; H Dong; K Tamada; J Ni; L Chen
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells.

Authors:  D Jarrossay; G Napolitani; M Colonna; F Sallusto; A Lanzavecchia
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

Review 3.  Interferon-producing cells: on the front line in immune responses against pathogens.

Authors:  Marco Colonna; Anne Krug; Marina Cella
Journal:  Curr Opin Immunol       Date:  2002-06       Impact factor: 7.486

Review 4.  The right place at the right time: novel B7 family members regulate effector T cell responses.

Authors:  Linda Liang; William C Sha
Journal:  Curr Opin Immunol       Date:  2002-06       Impact factor: 7.486

Review 5.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 6.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

7.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

Authors:  M Cella; F Facchetti; A Lanzavecchia; M Colonna
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

Review 8.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

9.  Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.

Authors:  A Krug; A Towarowski; S Britsch; S Rothenfusser; V Hornung; R Bals; T Giese; H Engelmann; S Endres; A M Krieg; G Hartmann
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

10.  Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.

Authors:  N Kadowaki; S Ho; S Antonenko; R W Malefyt; R A Kastelein; F Bazan; Y J Liu
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  12 in total

1.  CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues.

Authors:  Vanja Sisirak; Nelly Vey; Béatrice Vanbervliet; Thomas Duhen; Isabelle Puisieux; Bernhard Homey; Edward P Bowman; Giorgio Trinchieri; Bertrand Dubois; Dominique Kaiserlian; Sergio A Lira; Alain Puisieux; Jean-Yves Blay; Christophe Caux; Nathalie Bendriss-Vermare
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

2.  Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.

Authors:  Cecilie Ammitzbøll; Lars Börnsen; Eva Rosa Petersen; Annette Bang Oturai; Helle Bach Søndergaard; Philippe Grandjean; Finn Sellebjerg
Journal:  J Neuroimmunol       Date:  2019-03-02       Impact factor: 3.478

3.  IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.

Authors:  Geok Choo Sim; Natalia Martin-Orozco; Lei Jin; Yan Yang; Sheng Wu; Edwina Washington; Deborah Sanders; Carol Lacey; Yijun Wang; Luis Vence; Patrick Hwu; Laszlo Radvanyi
Journal:  J Clin Invest       Date:  2014-01       Impact factor: 14.808

Review 4.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

Review 5.  T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

Authors:  David J Kahler; Andrew L Mellor
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

Authors:  Tomoki Ito; Shino Hanabuchi; Yi-Hong Wang; Woong Ryeon Park; Kazuhiko Arima; Laura Bover; F Xiao-Feng Qin; Michel Gilliet; Yong-Jun Liu
Journal:  Immunity       Date:  2008-05-29       Impact factor: 31.745

7.  Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock.

Authors:  Gila Arad; Revital Levy; Iris Nasie; Dalia Hillman; Ziv Rotfogel; Uri Barash; Emmanuelle Supper; Tomer Shpilka; Adi Minis; Raymond Kaempfer
Journal:  PLoS Biol       Date:  2011-09-13       Impact factor: 8.029

8.  Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.

Authors:  Tomoki Ito; Maria Yang; Yui-Hsi Wang; Roberto Lande; Josh Gregorio; Olivia A Perng; Xiao-Feng Qin; Yong-Jun Liu; Michel Gilliet
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

Review 9.  Genetic defects in common variable immunodeficiency.

Authors:  O Kopecký; S Lukesová
Journal:  Int J Immunogenet       Date:  2007-08       Impact factor: 1.466

Review 10.  Targeting co-stimulatory molecules in autoimmune disease.

Authors:  Natalie M Edner; Gianluca Carlesso; James S Rush; Lucy S K Walker
Journal:  Nat Rev Drug Discov       Date:  2020-09-16       Impact factor: 112.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.